Riskpilot← Back to searchSign inGet full accessBELAIR MEDICAL ApS
APSActiveCVR 25465172Helga Pedersens Gade 79, 40. 6Engineering activities and related technical consultancy · NACE 7112Est. 20001 employees
Revenue 2024
DKK 98K
-64% vs 2023
EBITDA margin
87.4%
-55% vs 2023
Equity ratio
99.0%
Financial strength
Net profit 2024
DKK 4,2M
-26% vs 2023
| Revenue | DKK 98K | -64% |
| EBITDA | DKK 86K | -55% |
| Net profit | DKK 4,2M | -26% |
| Total assets | DKK 101,5M | +3% |
| Equity | DKK 100,5M | +4% |
| Employees | 1 | — |
Legal name
BELAIR MEDICAL ApS
CVR number
25465172
Legal form
Anpartsselskab
NACE code
7112 · Engineering activities and related technical consultancy
Founded
21. juni 2000
Share capital
DKK 135.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren
Company purpose
Selskabets formål er at beskæftige sig med medicinsk og medicoteknisk konsulentvirksomhed, herunder medicinske undersøgelser samt investering i aktier og anparter
Address
Helga Pedersens Gade 79, 40. 6
Phone
+4540634878
Email
email@peterbjerring.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 120 | -201 | 810 | 269 | 98 |
| Staff expenses | -93 | -51 | -345 | -77 | -12 |
| EBITDA | -5.600 | -253 | 465 | 193 | 86 |
| Depreciation & amort. | -54 | -47 | -457 | -18 | -0 |
| EBIT | -5.654 | -300 | 8 | 175 | 86 |
| Net financials | 5.157 | 5.572 | -7.951 | 6.638 | 5.186 |
| Profit before tax | -497 | 5.272 | -7.943 | 6.812 | 5.272 |
| Tax | 28 | 810 | -2.427 | 1.086 | 1.024 |
| Net profit | -525 | 4.462 | -5.515 | 5.726 | 4.247 |
| Item | 2021 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 103.156 | 109.382 | 103.482 | 98.868 | 101.452 |
| Equity | 90.566 | 96.358 | 90.728 | 96.336 | 100.462 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 12.589 | 13.015 | 12.754 | 2.531 | 990 |
| Total debt | 12.589 | 13.015 | 12.754 | 2.531 | 990 |
EBITDA margin
87.4%
This company
15.8%
Market median
+453% vs market
20212024
Equity ratio
99.0%
This company
38.2%
Market median
+159% vs market
20212024
Return on equity
4.2%
This company
18.4%
Market median
-77% vs market
20212024
Net profit margin
4327.6%
This company
8.1%
Market median
+53327% vs market
20212024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212024
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20212024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-05-01 – 2021-12-31
- Annual report 2021Filed via CVR / Virk · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
MH Management | Management | 2022 – 2023 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50–66.65% | 50–66.65% | 2024 | |
| Individual | 50–66.65% | 50–66.65% | 2024 | |
| Company | 100% | 100% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
BELAIR MEDICAL ApS (this company)
Egebjerg Bakke I A/SBoard members of BELAIR MEDICAL ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Maria Heickendorff | Management | 0 companies |